{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:01:47Z","timestamp":1757628107659,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91946","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:38:10Z","timestamp":1757482690000},"source":"Crossref","is-referenced-by-count":0,"title":["Pretreatment Voiding Volume as a Predictor of Post-brachytherapy Urinary Quality of Life in Patients With Prostate Cancer: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Naoto","family":"Wakita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Teishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Terakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89. 10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-007-0710-x","article-title":"Brachytherapy with permanent seed implantation","volume":"12","author":"Saito S","year":"2007","unstructured":"Saito S, Nagata H, Kosugi M, Toya K, Yorozu A. Brachytherapy with permanent seed implantation. Int J Clin Oncol. 2007, 12:395-407. 10.1007\/s10147-007-0710-x","journal-title":"Int J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(03)00784-3","article-title":"Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy \u226572 Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"58","author":"Kupelian PA","year":"2004","unstructured":"Kupelian PA, Potters L, Khuntia D, et al.. Radical prostatectomy, external beam radiotherapy &lt;72 Gy, external beam radiotherapy \u226572 Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004, 58:25-33. 10.1016\/s0360-3016(03)00784-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.06.035","article-title":"Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review","volume":"72","author":"Lardas M","year":"2017","unstructured":"Lardas M, Liew M, van den Bergh RC, et al.. Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review. Eur Urol. 2017, 72:869-85. 10.1016\/j.eururo.2017.06.035","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164048","article-title":"Prognostic factors for resolution delay of lower urinary tract symptoms in patients with prostate cancer after low-dose-rate brachytherapy","volume":"15","author":"Taniguchi T","year":"2023","unstructured":"Taniguchi T, Kawase M, Nakane K, et al.. Prognostic factors for resolution delay of lower urinary tract symptoms in patients with prostate cancer after low-dose-rate brachytherapy. Cancers (Basel). 2023, 15:4048. 10.3390\/cancers15164048","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2012.03105.x","article-title":"Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy","volume":"19","author":"Teishima J","year":"2012","unstructured":"Teishima J, Iwamoto H, Miyamoto K, et al.. Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy. Int J Urol. 2012, 19:1083-9. 10.1111\/j.1442-2042.2012.03105.x","journal-title":"Int J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer EM","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al.. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023, 21:1067-96. 10.6004\/jnccn.2023.0050","journal-title":"J Natl Compr Canc Netw"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(00)00858-x","article-title":"Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei JT","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000, 56:899-905. 10.1016\/s0090-4295(00)00858-x","journal-title":"Urology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5980\/jpnjurol1989.96.657","article-title":"The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index Composite (EPIC) (Article in Japanese)","volume":"96","author":"Takegami M","year":"2005","unstructured":"Takegami M, Suzukamo Y, Sanda MG, et al.. The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index Composite (EPIC) (Article in Japanese). Nihon Hinyokika Gakkai Zasshi. 2005, 96:657-69. 10.5980\/jpnjurol1989.96.657","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-005-0507-8","article-title":"Acute urinary morbidity following I-125 prostate brachytherapy","volume":"10","author":"Ohashi T","year":"2005","unstructured":"Ohashi T, Yorozu A, Toya K, Saito S, Momma T. Acute urinary morbidity following I-125 prostate brachytherapy. Int J Clin Oncol. 2005, 10:262-8. 10.1007\/s10147-005-0507-8","journal-title":"Int J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24744","article-title":"Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: an observational study using propensity score matching","volume":"84","author":"Nakai Y","year":"2024","unstructured":"Nakai Y, Tanaka N, Asakawa I, et al.. Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: an observational study using propensity score matching. Prostate. 2024, 84:1104-11. 10.1002\/pros.24744","journal-title":"Prostate"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2007.08.007","article-title":"Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume","volume":"6","author":"Petit JH","year":"2007","unstructured":"Petit JH, Gluck C, Kiger WS 3rd, et al.. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy. 2007, 6:267-71. 10.1016\/j.brachy.2007.08.007","journal-title":"Brachytherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05346.x","article-title":"Brachytherapy-related dysuria","volume":"95","author":"Merrick GS","year":"2005","unstructured":"Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Lief JH. Brachytherapy-related dysuria. BJU Int. 2005, 95:597-602. 10.1111\/j.1464-410X.2005.05346.x","journal-title":"BJU Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2014.08.047","article-title":"Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer","volume":"14","author":"Crook J","year":"2015","unstructured":"Crook J. Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer. Brachytherapy. 2015, 14:142-7. 10.1016\/j.brachy.2014.08.047","journal-title":"Brachytherapy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.0133","article-title":"Time trends and local variation in primary treatment of localized prostate cancer","volume":"28","author":"Cooperberg MR","year":"2010","unstructured":"Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010, 28:1117-23. 10.1200\/JCO.2009.26.0133","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24507","article-title":"Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy","volume":"83","author":"Nakai Y","year":"2023","unstructured":"Nakai Y, Tanaka N, Asakawa I, et al.. Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy. Prostate. 2023, 83:701-12. 10.1002\/pros.24507","journal-title":"Prostate"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2003.04231.x","article-title":"Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores","volume":"91","author":"Masters JG","year":"2003","unstructured":"Masters JG, Rice ML. Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores. BJU Int. 2003, 91:795-7. 10.1046\/j.1464-410x.2003.04231.x","journal-title":"BJU Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.2003.04658.x","article-title":"The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer","volume":"93","author":"Kumar V","year":"2004","unstructured":"Kumar V, Toussi H, Marr C, Hough C, Javle P. The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer. BJU Int. 2004, 93:507-9. 10.1111\/j.1464-410x.2003.04658.x","journal-title":"BJU Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2022.04.008","article-title":"Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy","volume":"21","author":"Nakai Y","year":"2022","unstructured":"Nakai Y, Tanaka N, Asakawa I, et al.. Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy. Brachytherapy. 2022, 21:626-34. 10.1016\/j.brachy.2022.04.008","journal-title":"Brachytherapy"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.02.027","article-title":"ASCENDE-RT: an analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda S","year":"2017","unstructured":"Rodda S, Morris WJ, Hamm J, Duncan G. ASCENDE-RT: an analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2017, 98:581-9. 10.1016\/j.ijrobp.2017.02.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rry101","article-title":"Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer","volume":"60","author":"Nakai Y","year":"2019","unstructured":"Nakai Y, Tanaka N, Asakawa I, et al.. Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer. J Radiat Res. 2019, 60:270-80. 10.1093\/jrr\/rry101","journal-title":"J Radiat Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405279-pretreatment-voiding-volume-as-a-predictor-of-post-brachytherapy-urinary-quality-of-life-in-patients-with-prostate-cancer-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:38:11Z","timestamp":1757482691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405279-pretreatment-voiding-volume-as-a-predictor-of-post-brachytherapy-urinary-quality-of-life-in-patients-with-prostate-cancer-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.91946","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}